ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/17/2019
Back to search
Official data from USPTO
AUSTARPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AUSTARPHARMA
ST13
US500000077166321Class
42
Filing
77166321
Registration
3465406
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
04/17/2019
Classification
Registered
Trademark type
Word
Nice classes
42
Filing date
04/26/2007
Registration date
07/15/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2018
Last transaction
11/08/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/12/2004
First use in commerce
07/18/2004
Drawing code
4
Owner type
03
Owner location
HONG KONG, CN
Examiner
CARLSEN, EMILY K
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
AUSTAR LTD
Austar International Limited
Representatives
JOSEPH SOFER Sofer & Haroun, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development and consultation related thereto in the field of pharmaceuticals, namely generic drug products
Publications
History of USPTO decisions and trademark events.
27 publications found
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED
11/08/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/08/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/08/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/31/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
10/31/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
07/28/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/28/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2014
E815
TEAS SECTION 8 & 15 RECEIVED
07/11/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
07/15/2008
PUBO
PUBLISHED FOR OPPOSITION
04/29/2008
NPUB
NOTICE OF PUBLICATION
04/09/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/19/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/19/2008
ALIE
ASSIGNED TO LIE
03/19/2008
PAPER RECEIVED
02/25/2008
DOCK
ASSIGNED TO EXAMINER
02/15/2008
CNRT
NON-FINAL ACTION MAILED
08/22/2007
CNRT
NON-FINAL ACTION WRITTEN
08/21/2007
DOCK
ASSIGNED TO EXAMINER
08/09/2007
MPMK
NOTICE OF PSEUDO MARK MAILED
05/01/2007
NWAP
NEW APPLICATION ENTERED
04/30/2007
Continuous trademark protection
Get notified about every new filing that threatens AUSTARPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.